EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

A case of hydralazine-induced bullous pemphigoid

Paul Zammit

AboutOpen · 13.03.2026 · 13 (1) · 14-15

DOI: 10.33393/ao.2026.3710 ↗

Kurz gefasst

Fachartikel in der Zeitschrift AboutOpen, online erschienen am 13.03.2026. Verfasst von Paul Zammit. Die Arbeit nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Hydralazine-induced bullous pemphigoid (BP) is a rare adverse drug reaction where the medicationmay act to trigger an autoimmune response against proteins in the dermal-epidermal junction (DEJ). This casehighlights the necessity of considering hydralazine as a potential cause of BP.Case Description: An 89-year-old Caucasian lady developed generalized, itchy, bullous rashes approximately twoweeks after her doctor initiated hydralazine for high blood pressure. BP secondary to hydralazine was suspected.A skin biopsy with direct immunofluorescence (DIF) confirmed the diagnosis, showing linear deposition of IgMand C3 along the basement membrane zone.

Conclusion

The cornerstone of management was the immediate discontinuation of hydralazine, and the patientwas started on oral prednisolone. Her rashes started disappearing within days and resolved within one month,demonstrating the good prognosis often seen with prompt drug withdrawal.

Zitieren

APA

Zammit, P. (2026). A case of hydralazine-induced bullous pemphigoid. AboutOpen, 13(1), 14-15. https://doi.org/10.33393/ao.2026.3710

Vancouver

Zammit P. A case of hydralazine-induced bullous pemphigoid. AboutOpen. 2026;13(1):14-15. doi:10.33393/ao.2026.3710

BibTeX
@article{Zammit2026,
  author = {Zammit, Paul},
  title = {A case of hydralazine-induced bullous pemphigoid},
  journal = {AboutOpen},
  year = {2026},
  volume = {13},
  number = {1},
  pages = {14--15},
  doi = {10.33393/ao.2026.3710}
}
Kostenlos starten →